Neurocrine Biosciences Inc (NASDAQ:NBIX)

79.40
Delayed Data
As of Apr 20
 +1.22 / +1.56%
Today’s Change
41.76
Today|||52-Week Range
92.98
+2.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.0019.8M15.0M161.6M
 
 
 
 
Cost of Goods Sold0.00----54.0K
 
 
Depreciation And Amortization827.0K1.0M1.5M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income-827.0K----159.2M
 
 
 
General Expenses63.6M113.0M160.9M290.5M
 
 
 
 
 
Research And Development46.4M81.5M94.3M121.8M
 
 
 
 
 
Total Operating Expenses64.4M114.0M162.4M293.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-64.4M-94.2M-147.4M-131.4M
 
 
 
 
 
Interest Expense On Debt--0.000.0019.5M
 
 
Other Expenses3.2M3.3M3.4M2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-60.5M-88.9M-141.1M-142.5M
 
 
 
 
 
Net Income-60.5M-88.9M-141.1M-142.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.6M84.5M86.7M88.1M
 
 
 
 
 
Shares To Calculate EPS Diluted74.6M84.5M86.7M88.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81-$1.05-$1.63-$1.62
 
 
 
 
 
EPS Diluted-$0.81-$1.05-$1.63-$1.62